rct
2023
High Quality
The efficacy and safety of β-nicotinamide mononucleotide supplementation in healthy middle-aged adults: a randomized, multicentre, double-blind, placebo-controlled, dose-dependent clinical trial
Yi L, Maier AB, Tao R
Published in GeroScience
Key Findings
NMN raised blood NAD+ dose-dependently and improved walking distance and a subjective wellbeing score, but not most other endpoints.
Conclusions
Biomarker change with limited functional translation.
Limitations
Industry funded, self-reported outcomes.
Supplements Studied
NMN
Compound
NMN raised blood NAD+ dose-dependently and improved walking distance, but most endpoints were unchanged.
Vitamin B3
Vitamin
NMN raised blood NAD+ dose-dependently and improved walking distance and a subjective wellbeing score, but not most other endpoints.
Outcomes Measured
NMN raised NAD+ dose-dependently but improved few functional ageing endpoints.
Study Details
Year:2023
Sample Size:80
Duration:8 weeks
Quality Score:7/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.